Oral absorption |
Good(60-80%), IV also |
Plasma protein binding |
25% |
Plasma half life |
40hrs |
Elimination |
Renal excretion |
Dose adjustment in |
Kidney failure |
Uses |
Routine treatment and emergency |
Target concentration |
1ng/ml |
Toxic concentration |
>2ng/ml |
Adverse effects and toxicity:
Earliest adverse effect |
Nausea, vomiting |
Adverse effect |
Nausea, vomiting |
Cardiac adverse effect |
Arrhythmias |
Arrhythmia |
Ventricular bigeminy |
Most characteristic arrhythmia |
Non paroxysomal supraventricular tachycardia with variable AV block |
Other adverse effects |
Gynaecomastia |
WhatsApp us